[Therapy of tuberculous meningitis].
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D003638:Deafness / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
D000995:Antitubercular Agents; D011239:Prednisolone; D013307:Streptomycin
Zur Therapie der Meningitis tuberculosa.